Skip to content

[BREAKING] Hemerion obtains the FDA clearance for its next US clinical trial

Company
Therapeutic solutions
Demos & Training
News
Careers
Investors
Press
Patients
Contact
Search the site

Contact

FR

Company
Therapeutic solutions
Demos & Training
News
Careers
Investors
Press
Patients
Contact
Search the site

Journal of Neuro-Oncology

- Company
- Therapeutic solutions
- News
- Careers
- Investors
- Press
- Patients
- Newsletter

- Legal notice
- Privacy policy
- Cookies Policy

Hemerion
Les Prés - BusinessPole A3
37 rue Denis Papin
59650 VILLENEUVE D’ASCQ
France

Contact

Company
Therapeutic solutions
Demos & Training
News
Careers
Investors
Press
Patients
Contact
Search the site

FR